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Background: Firefighters exposed to World Trade Center (WTC) dust have developed chronic rhi-
nosinusitis (CRS) andabnormal forcedexpiratory volume in 1 s (FEV1). Overlapping but distinct im-
mune responses may be responsible for the clinical manifestations of upper and lower airway
injury. We investigatedwhether a panel of inflammatory cytokines, either associated or not asso-
ciated with WTC-LI, can predict future chronic rhinosinusitis disease and its severity.
Methods: Serum obtained within six months of 9/11/2001 from 179 WTC exposed firefighters
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CRS chronic rhinosinusit
FDNY Fire Department Cit
FEV1 forced expiratory vo
GRO growth-regulated on
IL-6 interleukin-6
IL-8 interleukin-8
LLN lower limit of norm
MME medical monitoring
NHANESNational Health and
Examination Survey
PFT pulmonary function
PM particulate matter
PMN polymorphonuclear
SPE subspecialty pulmon
TNF-a tumor necrosis facto
WTC World Trade Center
WTC-LI World Trade Center
airway injurymain outcomes were medically managed CRS (N Z 62) and more severe CRS cases requiring
sinus surgery (N Z 14). We tested biomarker-CRS severity association using ordinal logistic
regression analysis.
Results: Increasing serum IL-6, IL-8, GRO and neutrophil concentration reduced the risk of
CRS progression. Conversely, increasing TNF-a increased the risk of progression. In a multi-
variable model adjusted for exposure intensity, increasing IL-6, TNF-a and neutrophil con-
centration remained significant predictors of progression. Elevated IL-6 levels and
neutrophil counts also reduced the risk of abnormal FEV1 but in contrast to CRS, increased
TNF-a did not increase the risk of abnormal FEV1.
Conclusions: Our study demonstrates both independent and overlapping biomarker associa-
tions with upper and lower respiratory injury, and suggests that the innate immune response
may play a protective role against CRS and abnormal lung function in those with WTC expo-
sure.
ª 2013 The Authors. Published by Elsevier Ltd.Open access under CC BY-NC-ND license.is
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The World Trade Center (WTC) collapse produced vast
quantities of respirable dust affecting Fire Department of
New York (FDNY) rescue workers, other exposed workers,
lower Manhattan residents and children [1e6]. WTC dust
was alkaline (pH, 9.2e11.5) and was comprised of metals,
radionuclides, ionic species, asbestos, polycyclic aromatic
hydrocarbons, polychlorinated biphenyls, polychlorinated
dibenzodioxines and other potentially hazardous materials.
The bulk of WTC particulate matter (PM) was larger than
10 mm, which usually is filtered in the nasopharynx [7].
However, the body’s usual protective barriers were over-
whelmed, producing intense dust exposure to both the
upper and lower airways [2].
A high incidence of upper and lower airway respiratory
disorders has persisted in WTC exposed firefighters years
after 9/11 [8]. Chronic rhinosinusitis (CRS) has been themost common manifestation of upper airway injury in this
population. Prior to 9/11, only 4.4% of FDNY firefighters
reported rhinosinusitis symptoms. By one year after 9/11,
self-reported rhinosinusitis symptoms had increased 10-fold
(45.1%) and persisted above 30% well into the fifth year
after 9/11 [9,10]. Numerous disability claims arising from
respiratory disorders such as CRS have had substantial
financial ramifications [11].
Shared upper and lower airway immune response is well
established in the spectrum of atopic rhinosinusitis and
allergic asthma [12e14] and as a cause of chronic cough
syndrome [15]. CRS in the FDNY firefighter cohort exists
both in isolation and in accompaniment with WTC lower
airway injury (WTC-LI) [16], portending overlapping but
distinct immune pathogenesis of irritant-induced upper
and lower airway injury. The pathophysiology of CRS
after occupational irritant exposure has not been well
characterized.
We have previously reported inflammatory biomarkers
that are predictive of future abnormal lung function in the
FDNY firefighter cohort [17]. No biomarker studies have
been published that predict the long-term outcome of
upper airway disease in this population. We investigated
whether a panel of inflammatory cytokines, either associ-
ated or not associated with WTC-LI, can predict future
chronic rhinosinusitis disease and its severity.Methods
Study design
All WTC exposed FDNY workers were enrolled in the
Medical Monitoring and Treatment Program. FDNY workers
(N Z 1720) who complained of any respiratory symptoms
between October 1, 2011 and March 10, 2008 were sys-
tematically sent for subspecialty pulmonary evaluation
(SPE). We performed a nested caseecohort study on fire-
fighters using this baseline cohort of 1720 exposed, symp-
tomatic workers. Study subgroups were derived from the
baseline cohort after excluding for patients with prior lung
or sinus disease. Fig. 1. Chronic rhinosinusitis (CRS) in our
study was defined as nasal and/or sinus inflammation, with
WTC Exposed FDNY workers Medical 
Monitoring and Treatment Program N=12,781 
Subspecialty Pulmonary Evaluation N=1,720
Inclusion Criteria:
i. Never smoking male FDNY rescue workers
ii. No pre-9/11 lung disease (FEV % predicted≥75)
iii. No prior sinus disease
iv. High or intermediate WTC exposure (arrival time 
before 9/13)
v. Accurate NHANES normative Data
vi. Serum from Medical Monitoring Entry with 
biomarkers assayed
Sinusitis Cases
N=76
Surgical 
Sinusitis
N=14
No Sinusitis
N=103
Medical 
Sinusitis
N=62
Study Cohort N=179
Figure 1 Study design. WTC Z World Trade Center;
FDNY Z Fire Department City of New York; FEV1 Z forced
expiratory volume in 1 s; NHANES Z National Health and
Nutrition Examination Survey.
164 S.J. Cho et al.recurrence of symptoms after re-exposure to irritants [16].
The diagnosis of chronic rhinosinusitis was determined by
the evaluating physician and was confirmed by sinus CT
scan and treated medically with nasal saline lavage, nasal
steroids decongestant and proton pump inhibitor [18]. The
time of CRS diagnosis was abstracted from the FDNY elec-
tronic medical record (FDNY-eMR). Of the 179-study pa-
tients, whose serum were available for biomarker assay, 76
developed CRS; 62 were medically managed and 14 were
refractory to medical management and elected to have
sinus surgery. Refractory was defined as requiring at least 3
months of medical management with persistent symptoms,
despite reported medication adherence that substantially
interfered with the patient’s quality of life. Once medical
management failed, patients were referred to ENT sub-
specialty clinic. For our analysis of progression, we
confirmed in the FDNY-eMR an ordered progression from no
CRS prior to 9/11/01 to post-9/11/01 medically managed
sinusitis and, when refractory to medical management, to
surgically managed sinusitis. Subjects signed informed
consents approved by the institutional review boards of
Montefiore Medical Center (#07e09e320) and New York
University (#11e00439).
Demographics
Age, race and years of service at FDNY were obtained
from the FDNY-WTC-monitoring database. Body mass
indices (BMIs) were calculated from height and weight
measured at the time of serum draw. Degree of exposure
was self-reported at the first FDNY-WTC-monitoring and
was categorized using the FDNY-WTC Exposure Intensity
Index (Arrival Time): i. Presented on the morning of 9/11/
2001 and ii. Arrived between afternoon on 9/11/2001 and
9/12/2001 [17,19]. Those arrived after day-three wereexcluded from analysis as a result of their low numbers in
this sample. Subjects underwent spirometry at the time of
serum collection as previously described [17,19,20].Serum sampling and analysis
Blood drawn at the first post-9/11 FDNY-WTC-monitoring
exam was processed as described [17]. Serum was
thawed once at 4 C and assayed using a pro-
inflammatory panel (39-Plex including EGF, Eotaxin,
FGF-2, Flt-3 ligand, Fractalkine, G-CSF, GM-CSF, GRO,
IFN-a2, IFN-g, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15,
IL-17, IL-1Ra, IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7,
IL-8, IL-9, IP-10, MCP-1, MCP-3, MDC (CCL22), MIP-1a,
MIP-1b, TGF-a, TNF-a, TNF-b, VEGF, sCD40L, sIL-2Ra,
Millipore, Billerica, MA) and Metabolic Hormone Panel
(13-Plex including Amylin, C-Peptide, Ghrelin, GIP, GLP-
1, Glucagon, IL-6, Insulin, Leptin, MCP-1, PP, PYY, TNF-
a, Millipore, Billerica, MA) according to manufacturer’s
instructions (Millipore) and analyzed on a Luminex 200IS
(Luminex Corporation).Statistical analysis
We tested normality using the ShapiroeWilk test and QeQ
plots. JonckheereeTerpstra or Wilcoxon rank-sum
tested for group comparisons. The Chi-squared or
Fisher’s exact tested for inferences on proportions.
Ordinal logistic regression analysis with the proportional-
odds model tested association between inflammatory
biomarkers and progressive sinusitis severity. The
approximate likelihood-ratio test of proportionality of
odds and the Brant test of parallel lines assumption
assessed model appropriateness. Since biomarkers were
severely skewed, we log-transformed them before
including them as continuous covariates in the model.
Logistic regression was used to assess the association
between biomarkers and abnormal forced expiratory
volume in 1 s (FEV1 less than lower limit of normal). A
two-sided P-value less than 0.05 was considered signifi-
cant. All analyses were performed with STATA/SE version
12.1 (StataCorp LP, College Station, TX).Results
Study design and demographics
The derivation of medical CRS cases, surgical CRS cases and
controls with no sinusitis during the study period is
described in Fig. 1. Demographics of the baseline cohort
and all study subgroups are shown in Table 1. Serum ob-
tained for biomarker analysis was drawn on average 2e3
months post-9/11. There was no significant difference in
the time to serum collection amongst these subgroups
(P Z 0.118). Cases and controls had similar age at 9/11,
years of firefighting service, body mass index, racial dis-
tribution and WTC exposure intensity. There were no sig-
nificant differences in spirometric parameters including
FEV1 and FEV1/FVC in cases versus controls.
Table 1 Demographics.
Control Medical cases Surgical cases P-valuee
Number of subjects 103 62 14
Age at 9/11a 41 (36e45) 41 (36e44) 42 (38e46) 0.880
Years of service at 9/11a 15 (8e18) 13 (6e17) 12 (9e16) 0.135
Raceb Caucasian 99 (96) 62 (98) 14 (100) 0.550
African American 4 (4) 1 (2) 0 (0)
Intensity of WTC Exposureb Highc 20 (19) 13 (21) 4 (29) 0.775
Intermediated 83 (81) 50 (79) 10 (71)
Time toa Serum Collection, months 2.6 (2.2e3.7) 2.6 (2.0e3.2) 2.3 (1.8e2.9) 0.118
Spirometry, months 35.7 (23e55) 31.7 (24e55) 43.8 (30e55) 0.550
Spirometrya FEV1, % Predicted 87 (74e99) 85 (73e95) 101 (88e107) 0.608
FEV1/FVC, % 76 (70e80) 76 (70e82) 77 (75e81) 0.263
Definition of abbreviations: WTC Z World Trade Center, FEV1 Z forced expiratory volume in 1 s; FVC Z forced vital capacity.
a Values expressed as median (IQR).
b Values expressed as N (%).
c Arrival at WTC 9/11 morning.
d Arrival at WTC between noon of 9/11 and midnight of 9/12.
e Significance assessed by JonckheereeTerpstra test or Chi-squared test between medical cases, surgical cases and controls.
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KaplaneMeier estimator was used to assess the cumulative
proportion of CRS. The incidence of CRS steadily increased
over study period, Fig. 2 Panel A. We examined the pro-
portion of the study cohort with sinusitis alone, abnormal
FEV1 alone or sinusitis with abnormal FEV1. Fourteen
percent (25/179) had both diagnoses, 28% (51/179) had onlyAbnormal 
FEV
1
Sinusitis
51
(28%)
25
(14%) 35
(20%)
68 (38%)
A.
B.
C
u
m
u
l
a
t
i
v
e
 P
r
o
p
o
r
t
i
o
n
 o
f
 C
R
S
 
(
%
)
Time (months)
100
80
60
40
20
0
0 20 12040 60 80 100
Figure 2 A. KaplaneMeier estimator was used to assess the
cumulative proportion of CRS. The incidence of CRS steadily
increased over study period. B. We examined the proportion of
the study cohort with sinusitis alone, abnormal FEV1 alone or
sinusitis with abnormal FEV1. Fourteen percent (25/179) had
both diagnoses, 28% (51/179) had only sinusitis and 20% (35/
179) had only abnormal FEV1.sinusitis and 20% (35/179) had only abnormal FEV1, Fig. 2
panel B.
Characteristics of chronic rhinosinusitis
The median time from 9/11 to CRS diagnosis was between
39 and 40 months in medical and surgical cases. The sub-
specialty pulmonary evaluation (SPE) spirometry occurred 7
months before the diagnosis of CRS in the medically
managed cases and 4 months after the diagnosis of CRS in
surgical cases, Table 2. Eighty three percent of CRS cases
(63/76) had CT scans available for analysis including 50
medical and 13 surgical CRS cases. The median time from
9/11 to sinus CT scan was 77 months in both medical and
surgical cases, respectively (PZ 0.322). Polypoid pathology
on CT scan was more prevalent in surgical than medical
cases; 46% (6/13) of surgically and 10% (5/50) of medically
managed CRS patients had polypoid sinusitis (P Z 0.007).
Univariable ordinal logistic regression
Assuming an ordered progression of severity from no
sinusitis to medically managed sinusitis to sinusitis requiring
surgery, we modeled biomarker ability to predict sinus
disease status. We included a panel of 39 cytokines,
neutrophil concentration and potential confounders such as
age, BMI and exposure intensity in the initial analysis.
Interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis
factor-alpha (TNF-a), growth-regulated oncogene (GRO),
neutrophil counts and BMI had a P-value less than 0.2 and
were therefore included in the multivariable ordinal logis-
tic model, Table 3.
Multivariable ordinal regression model
After adjustment for exposure intensity, IL-6, TNF-a and
neutrophil concentration made it into the final model,
Table 4. Increasing IL-6 and neutrophil counts increased the
Table 2 Characteristics of chronic sinusitis in FDNY
cohort.
Medical cases Surgical cases P-valuec
Time to SPE,
monthsa
31.7 (24e55) 43.8 (30e55) 0.319
Time to sinusitis
diagnosis,
monthsa
39 (13e65) 40 (23e79) 0.634
Time to sinus
CT scan,
monthsa,d
77 (52e98) 77 (57e104) 0.616
Polypsb,d 5 (10) 6 (46) 0.007
Definition of abbreviations: SPE Z subspecialty pulmonary
evaluation; CT Z computed tomography.
a Values expressed as median (IQR).
b Values expressed as N (%).
c Significance assessed by Wilcoxon rank-sum test and Fishers
exact test between medical cases and surgical cases.
d CT scans available: medical cases N Z 50; surgical cases
N Z 13.
166 S.J. Cho et al.odds of being in the control, non-sinusitis group. With every
1 log10pg/mL increase in IL-6, the probability of being in the
control group increased by 10.6% while the probabilities of
being in the medical and surgical sinusitis groups decreased
by 7.8% and 2.8%, respectively. Similarly, with every
1000 cells/mL increase in neutrophil count, the probability
of being in the control group increased by 8.8% while the
probabilities of being in the medical and surgical sinusitis
groups decreased by 6.5% and 2.3%, respectively.
Conversely, elevated TNF-a levels increased the odds of
having surgically managed sinusitis. Every 1 log10pg/mL
increase in TNF-a level resulted in a 20.4% lower probability
of being in the control group, 15.1% higher probability of
being in the medical sinusitis group and 5.3% higher prob-
ability of being in the surgical group.
Biomarkers of chronic rhinosinusitis with polyps
Since surgical patients had a 7.7 fold (95% CI: 1.8e32)
increased odds of sinus polyps we investigated biomarkers
of polyps in this cohort. We observed that increasing serum
eotaxin, interferon-gamma (IFN-g), interleukin-4 (IL-4),
interleukin-13 (IL-13), vascular endothelial growth factor
(VEGF), and neutrophil concentration reduced the risk ofTable 3 Predictive biomarkers and univariable ordinal logistic
Predictor Controlsa Medical casesa
IL-6 (log10pg/mL) 5.7 (1.7e17.7) 2.6 (0.7e12.2)
IL-8 (log10pg/mL) 16.4 (11.7e35.0) 12.6 (9.4e22.7)
TNF-a (log10pg/mL) 4.0 (2.6e5.5) 4.3 (2.8e5.8)
GRO (log10pg/mL) 732 (487e973) 641 (474e871)
BMI, kg/m2 27.9 (26e31) 29.1 (26e31)
PMN count, 103 3.8 (3.0e4.5) 3.6 (2.8e4.2)
Definition of abbreviations: OR Z odds ratio; PMN Z polymorphonuc
a Values expressed as median (IQR).
b Analysis was done between medical cases, surgical cases and conhaving CRS with polyps. Conversely, increasing eosinophil
concentration increased the risk of CRS with polyps, Table
5. In a multivariable model adjusted for exposure in-
tensity, each 1 log10pg/mL increase in IFN-g and IL-4
decreased the odds of having sinus polyps by 96% (95% CI:
0.00e0.99) and 80% (95% CI: 0.06e0.75) respectively. Each
1000 cells/mL increase of neutrophil count was associated
with 96% (95% CI: 0.01e0.48) decrease the odds of sinus
polyps while each 10 cells/mL increase of eosinophil count
increased the risk of developing polyps by 15% (95%CI:
1.03e1.27), Table 6.Biomarkers of sinus disease as predictors of
FEV1< LLN
We have previously reported biomarkers of inflammation
that predict FEV1 below the lower limit of normal (LLN) in
WTC exposed firefighters, and previously reported that
macrophage derived chemokine (MDC) and granulocyte
macrophage colony stimulating factor (GM-CSF) increased
the risk of abnormal FEV1 years later. We therefore inves-
tigated if inflammatory biomarkers of sinus disease pre-
dicted abnormal FEV1 in this cohort. We observed that each
1 log10pg/mL increase in IL-6 decreased the odds of
abnormal FEV1 by 65% (95% CI: 0.19e0.62) and that each
1000 cells/mL increase of neutrophil count was associated
with 40% decrease in the risk of abnormal FEV1 (95% CI:
0.43e0.83) in a model adjusted for exposure, BMI, age, MDC
and GM-CSF. TNF-a levels didn’t have statistically signifi-
cant association with lung function in this cohort.Discussion
Years after 9/11, a high incidence of both upper and lower
airway respiratory disorders has persisted in WTC exposed
firefighters [8], with CRS representing both the most com-
mon manifestation of upper airway injury in this cohort and
a condition of substantial morbidity [11]. The FDNY has
reported that 80% of previously healthy firefighters com-
plained of rhinosinusitis symptoms the first day after 9/11/
2001, 25% during the first year after exposure, and 32%
during the next 2e4 years [21]. In our study cohort who
presented to the subspecialty pulmonary evaluation, 42% of
WTC exposed firefighters were diagnosed with CRS, 4 times
higher than physician diagnosed sinusitis in the total cohort
(N Z 10,943) [22].regression predicting sinus disease severity.
Surgical casesa Crude OR (95%CI)b P-value
4.8 (3.1e13.6) 0.72 (0.48e1.09) 0.118
11.8 (9.0e21.8) 0.41 (0.19e0.90) 0.023
5.0 (2.3e8.7) 1.93 (1.00e3.80) 0.044
620 (506e952) 0.41 (0.11e1.50) 0.174
29.8 (28e32) 1.05 (1.03e1.14) 0.163
3.3 (2.6e3.9) 0.73 (0.57e0.94) 0.011
lear neutrophils; 95%CI Z 95% confidence interval.
trols.
Table 4 Multivariable ordinal logistic regression: final
model predicting sinus disease severity using stepwise
approach.
Predictor OR (95%CI)a P-value
IL-6 (log10pg/mL) 0.65 (0.42e1.00) 0.049
TNF-a (log10pg/mL) 2.31 (1.15e4.65) 0.018
PMN count, 103 0.69 (0.53e0.91) 0.008
Definition of abbreviations: OR Z odds ratio; IL-
6 Z interleukin-6; TNF-a Z tumor necrosis factor-alpha;
PMN Z polymorphonuclear neutrophils; 95%CI Z 95% confi-
dence interval.
a Adjusted for exposure intensity. Omnibus test
c2(4) Z 15.30, P Z 0.004. Approximate likelihood-ratio test of
proportionality of odds P Z 0.424. Brant test of parallel lines
P Z 0.347.
Table 6 Multivariable logistic regression: final model
predicting CRS with polyps.
Predictor OR (95%CI)a P-value
IFN-g (log10pg/mL) 0.04 (0.00e0.99) 0.050
IL-4 (log10pg/mL) 0.20 (0.06e0.75) 0.016
PMN count, 103 0.06 (0.01e0.48) 0.008
Eosinophil count, 10 1.15 (1.03e1.27) 0.009
Definition of abbreviations: OR Z odds ratio; IL-
4 Z interleukin-4; IFN-g Z interferon-gamma;
PMN Z polymorphonuclear neutrophils; 95%CI Z 95% confi-
dence interval.
a Adjusted for exposure intensity. Omnibus test
c2(5) Z 26.87, P < 0.001. Approximate likelihood-ratio test of
proportionality of odds P Z 0.737.
One airway, biomarkers of both upper and lower airway 167Whereas we have previously reported biomarkers of
inflammation predicting abnormal FEV1 in WTC exposed
firefighters, this is the first study to report a panel of in-
flammatory biomarkers that predict both future CRS dis-
ease and its progression or severity in this population.
Specifically, IL-6 and neutrophil concentration were found
to be protective against CRS, whereas TNF-a was a risk
factor for CRS progression or severity. Interestingly, in this
same group of patients using identical blood samples,
increased IL-6 levels and neutrophil counts were likewise
protective against an abnormal FEV1. In contrast, TNF-a
was not a risk factor for an abnormal FEV1 post-9/11 [17].
That we found both independent (TNF-a) and over-
lapping (IL-6, neutrophil counts) biomarker association with
irritant-induced upper and lower airway injury suggests
shared but distinct immune pathways. Indeed, there ap-
pears to be considerable clinical overlap between CRS and
lower airway injury as WTC-LI was a common comorbidity
of CRS in this cohort. Twenty-five out of 79 (32%) previously
healthy firefighters who developed CRS also developed
obstructive airway dysfunction post-9/11. This finding is
consistent with a prior report that 40% of WTC rescue
workers were diagnosed with both CRS and obstructive
airway disease post-9/11 [23].
The one-airway or unified airway concept linking the
upper and lower airways is already a well recognized and
accepted in asthma and allergic rhinitis [12,13] and inTable 5 Predictive biomarkers and univariable logistic regressi
Predictor CRS without polypsa
N Z 52
CR
N
Eotaxin (log10pg/mL) 125 (93e172) 7
IFN-g (log10pg/mL) 8.1 (4.8e20.1) 7.
IL-4 (log10pg/mL) 3.2 (0.5e9.1) 0.
IL-13 (log10pg/mL) 3.0 (0.5e18.7) 1.
VEGF (log10pg/mL) 144 (88e247) 6
PMN count, 103 3.6 (2.9e4.2) 2.
Eosinophil count, 10 16 (11e23) 2
Definition of abbreviations: ORZ odds ratio; IFN-gZ interferon-gamm
endothelial growth factor; PMN Z polymorphonuclear neutrophils; 95
a Values expressed as median (IQR).chronic cough syndrome [15]. Numerous cross-sectional and
retrospective studies have demonstrated that allergic
rhinitis is a risk factor for the presence of asthma [24].
Potential mechanisms linking these upper and lower airway
disease states are the nasobronchial neural reflex (airway
hyperreactivity), drainage of pro-inflammatory material
from the nose to the lungs (common allergen), loss of
protective function of the nose, and inflammatory pro-
cesses characterized by eosinophilia and local IgE produc-
tion [14,25,26].
Several studies by Braunstahl [27,28] have shown that
stimulation with antigen at one respiratory site can result in
expression of inflammatory cytokines at a location distant
from the site of stimulation. The activation of Th2 lym-
phocytes in the nose can lead to the differentiation and
activation of immune cells from precursors in the nasal
mucosa and bone marrow, leading to recruitment of these
newly generated cells throughout the upper and lower
airways [14]. These findings suggest that there is “inflam-
matory crosstalk” occurring throughout a “unified” upper
and lower airway. However the pathophysiology of CRS and
WTC-LI after occupational irritant exposure has not been
previously described.
The biomarkers associated with CRS and/or WTC-LI
identified in this study are known to be important media-
tors of the innate immune system. This is consistent with
studies suggesting that the innate immune response plays
an important role in the pathogenesis of CRS as well ason predicting CRS with polyps.
S with polypsa
Z 11
Crude OR (95%CI) P-value
9 (65e432) 0.04 (0.00e1.49) 0.082
6 (3.3e9.3) 0.15 (0.02e1.32) 0.087
5 (0.1e2.2) 0.52 (0.26e1.03) 0.062
4 (0.5e6.9) 0.51 (0.21e1.27) 0.148
4 (48e94) 0.08 (0.01e0.70) 0.022
9 (2.5e3.4) 0.41 (0.18e0.94) 0.036
5 (18e43) 1.04 (1e1.09) 0.058
a; IL-4Z interleukin-4; IL-13Z interleukin-13; VEGFZ vascular
%CI Z 95% confidence interval.
168 S.J. Cho et al.obstructive airway disease [29e31]. Interestingly, we found
neutrophil concentration to be protective of both CRS and
abnormal FEV1. A recent genome-wide association study
(GWAS) demonstrated an association between poly-
morphisms of the neutrophil’s acyloxyacyl hydrolase
(AOAH) gene with CRS in two independent populations
[32,33]. The AOAH gene, which is known to contribute to
the host defense against bacterial LPS, has also been linked
to asthma [34,35]. It may appear counter-intuitive that
neutrophils, which are conventionally agents of inflamma-
tion, were a protective biomarker for CRS and WTC-LI in our
study. However, recent investigations have indeed sup-
ported the concept that anti-inflammatory cascades can be
mediated by neutrophils early in the innate immune
response [36,37].
In our investigation, IL-6 was identified as a protective
biomarker for both sinusitis and abnormal FEV1 as well.
Although many IL-6 related gene variants have previously
been associated with conditions such as asthma and COPD
[38,39], studies demonstrating association between IL-6
polymorphisms and susceptibility to CRS have been rare.
Interestingly, causeeeffect studies using transgenic mice
have pointed to a dual role for IL-6 in lower airway dis-
eases; 1) enhancing allergic airway inflammation and 2)
protecting against airway hyperreactivity/inflammation
[40e42].
TNF-a is a cytokine that is thought to play a central role
in pathogenesis in CRS [43,44]. In severe CRS, TNF-a syn-
ergizes with Th1 and Th2 to induce a chronic inflammatory
state [45,46]. Multiple studies showed that single nucleo-
tide polymorphisms (SNPs) in TNF-a have been associated
with nasal polyps [47e49]. In our cohort, elevated TNF-a
levels were a risk factor for severe sinusitis (typically
polypoid on CT) but not WTC-LI. Further investigation is
required to assess if TNF-a directly contributes to the in-
flammatory cascade in WTC-related CRS.
The traditional classification of allergic CRS into CRS
with polyps versus without polyps is useful in the general
population in whom the presence of polyps is strongly
associated with sensitivity to aspirin or nonsteroidal anti-
inflammatory drugs. Our cohort is unique in that develop-
ment of CRS was provoked by massive exposure to com-
bustion byproducts, with pathophysiology that could
potentially be different from classical allergic CRS. There is
a suggestion that the cytokines that reduced the risk of
developing polyps are different from the cytokines that
reduced the risk of CRS progression even though increasing
blood PMN were protective biomarkers for both conditions.
Alternately, increasing eosinophil concentration was a
strong risk factor for polyps but not CRS progression. This
suggests overlapping but distinct pathways to CRS pro-
gression and sinus polyps.
This study has several limitations. This is an explor-
atory study using a panel of inflammatory cytokines in
this longitudinally followed cohort. The findings of this
investigation need to be validated in lager studies and
animal models. Our FDNY firefighters cohort is unique as
they had massive acute exposure to WTC dusts. This
limits the generalizability of these finding to other study
populations with lower level PM exposure produced by
ambient air pollution. However this is at the same time a
strength of our paper since we can make a safeassumption that the etiology of sinusitis was WTC dust.
We did not have an unexposed control group to compare
and therefore we could not determine the direct effect
of WTC-PM exposure on serum biomarkers. In addition,
there is no good surrogate measure to estimate exposure
prior to 9/11 since all individual firefighters would have
had different rate of exposure even in each fire runs.
Replication of these findings in other longitudinally fol-
lowed populations with and without PM exposure will be
important to demonstrate the generalizability of our
findings.
Our study demonstrates distinct but overlapping
biomarker association between upper and lower airway
injury, and suggests that a common inflammatory pathway
may be shared by CRS and lung disease caused by WTC
exposure. The potential relationship between irritant-
induced CRS and lung injury may underlie preventive and
therapeutic strategies for these conditions by modulating
inflammation.Funding
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